GENE ONLINE|News &
Opinion
Blog

2021-08-31| Trials & Approvals

Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors

by Rajaneesh K. Gopinath
Share To
Speaking to GeneOnline, Eric Ostertag, CEO of Poseida Therapeutics, said, “Other CAR-T products have not had much success against solid tumors. They have been very successful for liquid tumors, but not outside of it. We are very excited because these results are encouraging not just from the perspective of mCRPC patients or anti-PSMA therapeutics but for CAR-T products, in general, against solid tumors. These are among the best responses ever seen.”

"This innovative Poseida PSMA-directed CAR T cell platform has demonstrated a robust anti-tumor response in patients with metastatic castration resistant prostate cancer” commented Susan F. Slovin, M.D., Ph.D., Associate Vice Chair of Academic Administration at Memorial Sloan Kettering Cancer Center, and investigator on the trial. “This is the first time that I have seen such impressive responses with an immunotherapy product. The responses of my patients in the trial are far beyond my expectations.”

GO Prime with only $1.49 now

LATEST
Recounting 25 Years of Genetic and Human Diversity Discovery With deCODE Founder Kari Stefansson
2022-05-26
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia
2022-05-25
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Lonza Signs CDMO Deal to Break Into Israeli Market
2022-05-25
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention
2022-05-24
Global Race to Track and Contain Monkeypox Outbreak
2022-05-24
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!